Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |